Shin David, Cummings Carson, Cheng David, Dinh Chandler, Im Daniel, Tang Timothy, Oh Isabella, Han Lauren, Carlson Patricia, Harianja Gideon, Razzouk Jacob, Danisa Olumide, Cheng Wayne
School of Medicine Loma Linda University, Loma Linda, California.
Socially Responsible Surgery Loma Linda University, Loma Linda, California.
J Health Econ Outcomes Res. 2025 Sep 8;12(2):108-115. doi: 10.36469/001c.143489. eCollection 2025.
The cost of medical procedures in the United States varies dramatically depending on the payment system, including Medicare, Medi-Cal (California's Medicaid program), private insurance, or lien-based payment models used in personal injury cases. Cost discrepancies can discourage physician participation in Medicare and Medi-Cal, potentially limit access to care for vulnerable patient populations, and complicate the determination of proper compensation in court.
To survey healthcare providers to determine reasonable costs for medical procedures, potentially aligning legal standards with healthcare costs.
An anonymous, 8-question electronic survey was distributed through Survey Legend® between February and September 2023 to providers in orthopedic surgery, neurosurgery, anesthesiology, interventional radiology (IR), physical medicine and rehabilitation (PMR), pain management, and physician assistants (PAs) or nurse practitioners (NPs). Three procedures-epidural injection, facet injection/medial branch block, and radiofrequency ablation-were included, with participants selecting from 5 cost categories: < 1000- 5000- 10000- 20,000. Additional questions explored participant insight into discounts for cash and lien-based payments.
For all procedures and participants, the most common value was 4999. Neurosurgery selected significantly higher epidural values than pain management (=.025), PMR (=.029), and PA/NP (=.04); higher facet injection/medial branch block values than PMR (=.03) and PA/NPs (=.01); and higher radiofrequency ablation values than PA/NPs (=.02). Physicians not accepting lien payments showed significantly lower values across all specialties and procedures.
The range of reported reasonable costs by respondents reflects a discrepancy between physician expectations and existing reimbursement models, indicating a lack of a standardized value for procedural pricing. Medicare's estimated 1000 for radiofrequency ablation are below both physician-perceived reasonable costs and the inflated charges often found in lien-based cases. In contrast, personal injury billing can reach as high as $20,000 for an epidural injection, a cost category that only 2.9% of survey respondents chose.
This survey highlights healthcare providers' perceptions of reasonable costs for procedures, possibly assisting in refining reimbursement models, ensuring consistency in legal proceedings, and maintaining proper accessibility and compensation for patients and providers.
在美国,医疗程序的费用因支付系统的不同而有巨大差异,支付系统包括医疗保险、医疗补助(加利福尼亚州的医疗补助计划)、私人保险,或人身伤害案件中使用的基于留置权的支付模式。费用差异可能会阻碍医生参与医疗保险和医疗补助项目,潜在地限制弱势群体获得医疗服务的机会,并使法庭上合理赔偿的判定变得复杂。
对医疗服务提供者进行调查,以确定医疗程序的合理费用,可能使法律标准与医疗费用保持一致。
2023年2月至9月期间,通过Survey Legend®向骨科手术、神经外科、麻醉学、介入放射学(IR)、物理医学与康复(PMR)、疼痛管理领域的医疗服务提供者以及医师助理(PA)或执业护士(NP)发放了一份包含8个问题的匿名电子调查问卷。调查涵盖了三种医疗程序——硬膜外注射、小关节注射/内侧支阻滞和射频消融,参与者从5个费用类别中进行选择:<1000美元、1000 - 5000美元、5000 - 10000美元、10000 - 20000美元。其他问题探讨了参与者对现金支付和基于留置权支付的折扣的看法。
对于所有医疗程序和参与者来说,最常见的费用值是4999美元。神经外科选择的硬膜外注射费用值显著高于疼痛管理(P =.025)、物理医学与康复(P =.029)以及医师助理/执业护士(P =.04);小关节注射/内侧支阻滞费用值高于物理医学与康复(P =.03)和医师助理/执业护士(P =.01);射频消融费用值高于医师助理/执业护士(P =.02)。不接受留置权支付的医生在所有专科和医疗程序中的费用值显著更低。
受访者报告的合理费用范围反映了医生期望与现有报销模式之间的差异,表明程序定价缺乏标准化价值。医疗保险估计的射频消融费用1000美元低于医生认为的合理费用以及基于留置权案件中经常出现的虚高收费。相比之下,硬膜外注射的人身伤害计费可能高达20000美元,只有2.9%的调查受访者选择了这个费用类别。
这项调查突出了医疗服务提供者对医疗程序合理费用的看法,可能有助于完善报销模式,确保法律程序的一致性,并为患者和提供者维持适当的可及性和赔偿。